甲状腺眼病眶部放疗:美国眼科学会报告
本报告由美国眼科学会组织,检索截至2021年2月的PubMed文献,纳入18项关于眶部放疗治疗甲状腺眼病(TED)安全性和疗效的原创研究,所有研究证据等级均为III级。最佳证据提示,眶部放疗联合或不联合糖皮质激素可有效预防压迫性视神经病变、改善眼球运动受限和降低临床活动度,并可能有助于糖皮质激素减量。短期风险较小,但缺乏长期结局数据。
要点
- 纳入18项研究,证据等级均为III级,无I级或II级证据。
- 两项大型回顾性研究显示放疗联合或不联合糖皮质激素可预防或治疗压迫性视神经病变。
- 放疗可能有助于糖皮质激素减量、改善复视和软组织体征,短期风险较小但缺乏长期数据。
核心结论
- 尽管无I级或II级证据,最佳可用证据提示眶部放疗联合或不联合糖皮质激素可有效预防压迫性视神经病变、改善眼球运动受限和降低TED临床活动度。
- 眶部放疗还可能有助于糖皮质激素减量,这些研究显示放疗似乎可改变TED的活动期。
- 眶部放疗的短期风险较小,但缺乏长期结局数据。
研究设计与样本
- 美国眼科学会报告,通过PubMed数据库检索截至2021年2月的英文原创研究文献,评估眶部放疗对TED的作用。
- 检索共识别55篇文章,其中18篇符合纳入标准,由方法学家为每项研究分配证据等级,所有研究均为III级。
主要发现
- 两项大型回顾性研究显示放疗联合或不联合糖皮质激素在预防或治疗压迫性视神经病变方面有效。
- 三项研究强调眶部放疗有助于糖皮质激素减量。
- 若干其他研究显示放疗可能对改善复视和软组织体征有作用。
关键数值与推荐
- 所有18项纳入研究的证据等级均为III级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无I级或II级证据。
- 长期结局数据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To review the current literature on the safety and efficacy of orbital radiation for the management of thyroid eye disease (TED). METHODS: A literature search was conducted last in February 2021 of the PubMed database to identify all articles published in the English language on original research that assessed the effect of orbital radiation on TED. The search identified 55 articles, and 18 met the inclusion criteria for this assessment. A panel methodologist then assigned a level of evidence rating for each study, and all of them were rated level III. RESULTS: Two large retrospective studies demonstrated the efficacy of radiation treatment, with or without corticosteroid use, in preventing or treating compressive optic neuropathy (CON). Three studies highlighted the role of orbital radiation therapy (RT) to facilitate the tapering of corticosteroids. Several other studies showed a possible role for RT to improve diplopia and soft tissue signs. CONCLUSIONS: Although no level I or level II evidence exists, the best available evidence suggests that orbital radiation, used with or without corticosteroids, is efficacious in preventing CON, improving motility restriction, and decreasing clinical activity in TED. Orbital radiation also may facilitate a corticosteroid taper. Together, these studies show that RT seems to modify the active phase of TED. Short-term risks of orbital radiation are minor, but long-term outcome data are lacking.
引用
- Sobel RK, Aakalu VK, Vagefi MR, et al. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021. PMID: 34895729. doi:10.1016/j.ophtha.2021.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。